← Leaderboards
Andrei Maiseyeu
Case Western Reserve University
$5,576,899
Attributed
$6,429,091
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,429,091 · 4
By mechanism
R01$6,429,091 · 4
Top collaborators
- Sanjay Rajagopalan5 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Clifford V Harding$42,093,777
- Sanjay Rajagopalan$28,940,369
- Timothy S Kern$20,435,317
- Melvin Edward Medof$11,656,658
- Lawrence M Sayre$3,467,397
Others in their field
Top investigators on “Mortality”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$293,517,891
- Lawrence Corey · Fred Hutchinson Cancer Center$289,968,959
- Judith S. Currier · University Of California Los Angeles$286,517,393
- James Dennis Neaton · Northwestern University$278,695,034
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel R Kuritzkes · Brigham And Women'S Hospital$261,859,249
Research focus
MortalityMacrophageCellsChronicPublic HealthLipidsInflammatoryPhenotypeIn VivoImmuneMonocyteFlow CytometryInflammationCytokineIn VitroLaboratoriesOrganBloodDrug Delivery SystemsAnimalsAtherosclerosisCholesterolMetabolicCardiovascular Diseases
Grant awards (16)
Engineered polymeric adjuvants for heart-redirected targeting and gene therapy$594,531
R01 · FY2025 · HL · contact PI
Targets and targeting of immunometabolism in chronic PM2.5 exposure$402,500
R01 · FY2025 · ES · contact PI
Targets and targeting of immunometabolism in chronic PM2.5 exposure$94,385
R01 · FY2025 · ES · contact PI
Engineered polymeric adjuvants for heart-redirected targeting and gene therapy$579,425
R01 · FY2024 · HL · contact PI
Targets and targeting of immunometabolism in chronic PM2.5 exposure$402,500
R01 · FY2024 · ES · contact PI
Non-racemic metabolic biomaterials for HFpEF$402,500
R01 · FY2024 · HL · contact PI
Targets and targeting of immunometabolism in chronic PM2.5 exposure$402,500
R01 · FY2023 · ES · contact PI
Non-racemic metabolic biomaterials for HFpEF$402,500
R01 · FY2023 · HL · contact PI
Non-racemic metabolic biomaterials for HFpEF$402,500
R01 · FY2022 · HL · contact PI
Targets and targeting of immunometabolism in chronic PM2.5 exposure$402,500
R01 · FY2022 · ES · contact PI
Non-racemic metabolic biomaterials for HFpEF$402,500
R01 · FY2021 · HL · contact PI
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles$396,250
R01 · FY2020 · HL · contact PI
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles$396,250
R01 · FY2019 · HL · contact PI
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles$367,000
R01 · FY2018 · HL · contact PI
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles$396,250
R01 · FY2017 · HL · contact PI
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles$385,000
R01 · FY2016 · HL · contact PI